文献速递骨肌技术与安全PETCT

[18F]-FDG PET-CT肌肉与肌肉SUV比值对活动性皮肌炎诊断的临床价值

Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.
PubMed 文献 · Eur Radiol · 2019-06-27

回顾性纳入24例符合欧洲神经肌肉中心诊断标准的皮肌炎患者,以SUV近端肌肉/胸最长肌比值(SUVPROX/SUVMLT)与年龄性别匹配的24例黑色素瘤对照比较,阈值1.73诊断活动性皮肌炎的敏感度50%、特异度83.3%,去除无肌病性皮肌炎后特异度升至95%、似然比10、AUC 83.4%。

要点

  • 皮肌炎患者FDG-PET表现为近端肌肉对称性摄取增高。
  • SUVPROX/SUVMLT比值阈值1.73,诊断敏感度50%、特异度83.3%。
  • 去除无肌病性皮肌炎后特异度95%、似然比10、AUC 83.4%。

核心结论

  • FDG-PET中肌肉与肌肉SUVPROX/SUVMLT比值以1.73为界值,可能作为判断皮肌炎疾病活动的无创标志物。

研究设计与样本

  • 回顾性研究,通过全国性调查在3年期间识别24例符合欧洲神经肌肉中心诊断标准的皮肌炎患者,全部行肌肉活检,并与年龄性别匹配的24例接受FDG-PET的黑色素瘤对照比较。

关键影像表现/征象

  • 皮肌炎患者表现为近端和对称性肌肉摄取增高。
  • 在视觉分级中摄取最高的近端肌肉测量最大SUV(SUVPROX),在胸最长肌测量最大SUV(SUVMLT),肝脏测量平均SUV(SUVLIV)。

诊断标准与关键数值

  • 皮肌炎患者SUVPROX/SUVLIV与SUVMLT/SUVLIV比值差异有统计学意义(p < 0.001)。
  • 皮肌炎患者与对照的SUVPROX/SUVMLT比值差异有统计学意义(p = 0.0012)。
  • SUVPROX/SUVMLT比值区分皮肌炎与对照的阈值为1.73,敏感度50%(CI95%,29.1 to 70.9%),特异度83.3%(CI95%,62.6 to 95.3%)。
  • 去除无肌病性皮肌炎患者后,特异度升至95%(CI95%,75.1 to 99.9%),似然比10,AUC 83.4%(CI95%,71.4 to 95.4%)。
  • SUVPROX/SUVMLT比值大于1.73提示活动性疾病。

临床应用与阅片要点

  • 作者认为FDG-PET肌肉与肌肉SUVPROX/SUVMLT比值以1.73为界值,可能作为判断皮肌炎疾病活动的无创标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To study a muscle-to-muscle standardised uptake value (SUV) ratio with FDG-PET/CT (FDG-PET) as a marker for the detection of disease activity in dermatomyositis (DM).

METHODS: Patients with DM (n = 24) who met the European Neuro-Muscular Centre diagnostic criteria were retrospectively identified over a 3-year period through a national survey. Muscle biopsy was performed in all patients. Maximum SUV was measured in proximal muscles (SUVPROX) that had the highest radiotracer uptake on visual grading as well as in the musculus longissimus thoracis (SUVMLT), whereas mean SUV was measured for the liver (SUVLIV). Muscle-to-liver SUV ratios for either muscle group were compared and a SUVPROX/SUVMLT ratio was calculated. SUVPROX/SUVMLT of DM patients were compared with age- and sex-matched control subjects (n = 24) with melanoma who had received FDG-PET scans.

RESULTS: DM patients presented with proximal and symmetrical muscle uptake. Differences in SUVPROX/SUVLIV and SUVMLT/SUVLIV ratios in DM subjects were significant (p < 0.001). SUVPROX/SUVMLT ratios in DM and their controls also differed significantly (p = 0.0012). The SUVPROX/SUVMLT ratio threshold between DM subjects and controls was 1.73 with a sensitivity of 50% (CI95%, 29.1 to 70.9%) and specificity at 83.3% (CI95%, 62.6 to 95.3%). When amyopathic DM patients were removed from the analysis, specificity was increased to 95% (CI95%, 75.1 to 99.9%) with a likelihood ratio of 10 and an AUC of 83.4% (CI95%, 71.4 to 95.4%).

CONCLUSION: A muscle-to-muscle SUVPROX/SUVMLT ratio with a cut-off value of 1.73 in FDG-PET imaging might serve as a non-invasive marker to determine disease activity in dermatomyositis.

KEY POINTS: • [18F]-FDG PET-scanner standardised uptake value (SUV) could reflect disease activity in dermatomyositis (DM). • A ratio of SUV in proximal muscles (SUVPROX) to SUV in musculus longissimus thoracis (SUVMLT) could be used to determine active DM. • Active disease is suspected for SUV PROX /SUV MLT ratios greater than 1.73.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Martis N, Viau P, Zenone T, et al. Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis. Eur Radiol. 2019. PMID: 31250167. doi:10.1007/s00330-019-06302-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。